176 related articles for article (PubMed ID: 9762782)
1. Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients.
Tötterman KJ; Huhti L; Sutinen E; Backman R; Pietinalho A; Falck M; Larsson P; Selroos O
Eur Respir J; 1998 Sep; 12(3):573-9. PubMed ID: 9762782
[TBL] [Abstract][Full Text] [Related]
2. Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction.
Malolepszy J; Böszörményi Nagy G; Selroos O; Larsso P; Brander R
Eur Respir J; 2001 Dec; 18(6):928-34. PubMed ID: 11829098
[TBL] [Abstract][Full Text] [Related]
3. Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma.
Ind PW; Villasante C; Shiner RJ; Pietinalho A; Böszörményi NG; Soliman S; Selroos O
Eur Respir J; 2002 Oct; 20(4):859-66. PubMed ID: 12412676
[TBL] [Abstract][Full Text] [Related]
4. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study.
Ekström T; Ringdal N; Tukiainen P; Runnerström E; Soliman S
Ann Allergy Asthma Immunol; 1998 Sep; 81(3):225-30. PubMed ID: 9759798
[TBL] [Abstract][Full Text] [Related]
5. Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline.
Kaae R; Agertoft L; Pedersen S; Nordvall SL; Pedroletti C; Bengtsson T; Johannes-Hellberg I; Rosenborg J
Br J Clin Pharmacol; 2004 Oct; 58(4):411-8. PubMed ID: 15373934
[TBL] [Abstract][Full Text] [Related]
6. Formoterol used as needed in patients with intermittent or mild persistent asthma.
Chuchalin A; Kasl M; Bengtsson T; Nihlen U; Rosenborg J
Respir Med; 2005 Apr; 99(4):461-70. PubMed ID: 15763453
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
8. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
[TBL] [Abstract][Full Text] [Related]
9. Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis.
Vilsvik J; Ankerst J; Palmqvist M; Persson G; Schaanning J; Schwabe G; Johansson A
Respir Med; 2001 Jun; 95(6):484-90. PubMed ID: 11421506
[TBL] [Abstract][Full Text] [Related]
10. Dose-related efficacy and safety of formoterol (Oxis) Turbuhaler compared with salmeterol Diskhaler in children with asthma.
Pohunek P; Matulka M; Rybnícek O; Kopriva F; Honomichlová H; Svobodová T
Pediatr Allergy Immunol; 2004 Feb; 15(1):32-9. PubMed ID: 14998380
[TBL] [Abstract][Full Text] [Related]
11. A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients.
Schreurs AJ; Sinninghe Damsté HE; de Graaff CS; Greefhorst AP
Eur Respir J; 1996 Aug; 9(8):1678-83. PubMed ID: 8866594
[TBL] [Abstract][Full Text] [Related]
12. Single-dose comparison of formoterol (Oxis) Turbuhaler 6 microg and formoterol Aerolizer 12 microg in moderate to severe asthma: a randomised, crossover study.
Schlimmer P
Pulm Pharmacol Ther; 2002; 15(4):369-74. PubMed ID: 12220942
[TBL] [Abstract][Full Text] [Related]
13. Low-dose formoterol Turbuhaler (Oxis) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.).
Ekström T; Ringdal N; Sobradillo V; Runnerström E; Soliman S
Respir Med; 1998 Aug; 92(8):1040-5. PubMed ID: 9893773
[TBL] [Abstract][Full Text] [Related]
14. Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma.
Boonsawat W; Charoenratanakul S; Pothirat C; Sawanyawisuth K; Seearamroongruang T; Bengtsson T; Brander R; Selroos O
Respir Med; 2003 Sep; 97(9):1067-74. PubMed ID: 14509562
[TBL] [Abstract][Full Text] [Related]
15. Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics.
Rosenborg J; Bengtsson T; Larsson P; Blomgren A; Persson G; Lötvall J
Eur J Clin Pharmacol; 2000 Aug; 56(5):363-70. PubMed ID: 11009043
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
17. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
Richter K; Janicki S; Jörres RA; Magnussen H
Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients.
Singh D; Piccinno A; Borrill Z; Poli G; Acerbi D; Meuleners L; Woodcock A
Pulm Pharmacol Ther; 2008; 21(3):551-7. PubMed ID: 18321744
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma.
Ankerst J; Persson G; Weibull E
Pulm Pharmacol Ther; 2003; 16(3):147-51. PubMed ID: 12749830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
